Provectus Biopharmaceuticals, Inc.

Provectus Biopharmaceuticals, Inc.

PVCT
Provectus Biopharmaceuticals, Inc.US flagOther OTC
0.06
USD
- -
- -
25.22MMarket Cap

Provectus Biopharmaceuticals, Inc. (PVCT) Stock Split History

Learn about Provectus Biopharmaceuticals, Inc.'s most recent 1-for-300 basis stock split on April 11, 2002. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Provectus Biopharmaceuticals, Inc.'s most recent stock split

Split Date: 2002-04-11
Split Ratio: 1:300
Price Before Split: $0.01
Price After Split: $0.00

Developer API

Get PVCT split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/PVCT

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 300.00 times fewer shares (a 1:300 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Provectus Biopharmaceuticals, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2002-04-111:300Yes$0.01$0.00
2000-06-281:5000Yes$0.00$0.00

About Provectus Biopharmaceuticals, Inc.

Company overview and industry information

Provectus Biopharmaceuticals, Inc. (PVCT) operates in the Biotechnology industry. The recent 1-for-300 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Provectus Biopharmaceuticals, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.